LIBRIUM
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Jul 1961
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
2/8 — Basic
Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LIBRIUM is an injectable medication approved in 1961 as an NDA by Bausch + Lomb. The generic name and mechanism of action are not currently available in this dataset; however, given its approval date and injection route, it represents a legacy therapeutic agent. Specific indications cannot be determined from available data.
LOE Approaching
With LOE approaching and minimal commercial data available, the brand team is likely in consolidation or transition mode with limited expansion opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
Phage-based Control and Limitation of Pathobionts for Microbiome Equilibrium and Resilience
Started Sep 2026
40 enrolled
Gastrointestinal SymptomsSkin Quality
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
Started Sep 2026
20 enrolled
Major Depressive Disorder
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium - Maintenance
Started Aug 2026
10 enrolled
Major Depressive Disorder (MDD)
Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN
Started Aug 2014
140 enrolled
Complications; Cesarean SectionAnesthesia; Reaction
Worked on LIBRIUM at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.